CEO and CFO Buy Over $1M in Xenon Stock After 30% Plunge
XENE is trading near its 52-week low of $36.07 (8.7% above the low).
Summary
CEO Ian Mortimer bought $1.12M of Xenon stock at $37.38, and CFO Kelly Thomas Patrick bought $559,740 at $37.32, both open-market purchases. This follows the 30.7% plunge on September 18 after the company paused enrollment in its major depressive disorder trial. Insider buying at these levels signals management confidence in the azetukalner focal seizures NDA and the company's cash position. The purchases are the first open-market buys by the CEO in at least 90 days, adding weight to the signal.
At the time of this announcement, XENE was trading at $39.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $36.07 to $72.66. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.